Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice (vol 6, e2100133, 2022)

被引:0
|
作者
Schroder, Carsten
Gower-Page, Craig
Reyes-Rivera, Irmarie
Patel, Arisha
Price, Richard
Sen, Shiraj
Davies, Jessica
Castellanos, Emily
Snider, Jeremy
Bai, Xiaobo
Fisher, Virginia
Mhatre, Shivani K.
机构
来源
JCO CLINICAL CANCER INFORMATICS | 2022年 / 6卷 / 01期
关键词
D O I
10.1200/CCI.22.00042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice
    Schroeder, Carsten
    Gower-Page, Craig
    Reyes-Rivera, Irmarie
    Patel, Arisha
    Price, Richard
    Sen, Shiraj
    Davies, Jessica
    Castellanos, Emily
    Snider, Jeremy
    Bai, Xiaobo
    Fisher, Virginia
    Mhatre, Shivani K.
    JCO CLINICAL CANCER INFORMATICS, 2022, 6
  • [2] Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice (Mar, 10.1200/CCI.21.00133, 2022)
    Schroder, Carsten
    Gower-Page, Craig
    Reyes-Rivera, Irmarie
    Patel, Arisha
    Price, Richard
    Sen, Shiraj
    Davies, Jessica
    Castellanos, Emily
    Snider, Jeremy
    Bai, Xiaobo
    Fisher, Virginia
    Mhatre, Shivani K.
    JCO CLINICAL CANCER INFORMATICS, 2022, 6 (01):
  • [3] Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer
    Lima Jr, Nildevande F.
    Sampaio, Luana A. F.
    Xavier, Camila B.
    Mattedi, Romulo L.
    Queiroz, Marcelo A.
    Nahas, Willian C.
    Jardim, Denis L.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [4] Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial
    Imai, Mitsuho
    Nakamura, Yoshiaki
    Shin, Sangwon
    Okamoto, Wataru
    Kato, Takeshi
    Esaki, Taito
    Kato, Ken
    Komatsu, Yoshito
    Yuki, Satoshi
    Masuishi, Toshiki
    Nishina, Tomohiro
    Sawada, Kentaro
    Sato, Akihiro
    Kuwata, Takeshi
    Yamashita, Riu
    Fujisawa, Takao
    Bando, Hideaki
    Ock, Chan-Young
    Fujii, Satoshi
    Yoshino, Takayuki
    JCO PRECISION ONCOLOGY, 2025, 9
  • [5] How to Treat Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Amplified Breast Cancer
    Cortes, Javier
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5492 - 5494
  • [6] Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal Cancer
    Sartore-Bianchi, Andrea
    Marsoni, Silvia
    Siena, Salvatore
    JAMA ONCOLOGY, 2018, 4 (01) : 19 - 20
  • [7] Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer
    Henry, Kelly E.
    Ulaner, Gary A.
    Lewis, Jason S.
    PET CLINICS, 2018, 13 (03) : 423 - +
  • [8] The Association of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 with Prognosis of Colorectal Cancer under FOLFOX Chemotherapy
    Qian, H.
    Huang, Wenzhi
    Zhang, Y.
    Cheng, Xiaofei
    Zhong, C.
    Tian, F.
    Chu, Ziang
    Zhou, T.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 25 - 30
  • [9] New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer
    Britten, Karissa
    McAndrew, Nicholas
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2024, 36 (01) : 34 - 39
  • [10] Human epidermal growth factor receptor 2 status in breast cancer: A comparison between borderline positive human epidermal growth factor receptor 2 and strongly positive human epidermal growth factor receptor 2 tumors
    Huszno, Joanna
    Nowara, Elibieta
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (03): : 307 - 311